Search

everythinglearnresearchcommunity

for

Search:↓

Face mask-related injuries in U.S. emergency departments rose by 2400% during the COVID-19 pandemic, with most injuries being dermatitis and lacerations.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Genetic differences may affect COVID-19 deaths; anti-androgens could be potential treatment.

Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Mothers with lower stress during pregnancy but higher stress after birth had infants with lower development scores.

The study found that skin conditions in COVID-19 patients can signal serious internal organ damage and may be life-threatening.

Icosapent ethyl may help treat long-lasting symptoms after COVID-19.

Most hospitalized COVID-19 patients had long-term symptoms like fatigue and hair loss, with women and those sicker during hospitalization at higher risk.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Severe male balding may increase the risk of serious COVID-19, and treatments that reduce androgens or block a specific enzyme might help protect these individuals.

Hair loss link to severe COVID-19 unclear.

High incidence of hair loss found in COVID-19 patients, but no severity correlation established.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

COVID-19 affects multiple body systems and complicates treatment; accurate testing is crucial.

Skin symptoms linked to COVID-19 are hard to confirm, and more testing is needed to identify which are truly caused by the virus.

A COVID-19 patient had unusual nail discoloration and nail separation possibly due to the virus's effects on small blood vessels.

Some COVID-19 pneumonia patients in Veracruz, Mexico, had skin issues, with reversible hair loss linked to disease severity.

MAIT cells may help fight COVID-19 but also contribute to severe inflammation.

Some COVID-19 pneumonia patients in Veracruz, Mexico had rare skin issues like temporary hair loss linked to disease severity.

Male hormones like testosterone may make COVID-19 worse, and testing for sensitivity to these hormones could help predict how severe a patient's symptoms might be. Treatments that reduce these hormones are being explored.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

The research found that COVID-19 survivors experienced long-term effects like anemia and hypertension, with age and gender being important factors, but race, income, and education had little to no impact.

During the COVID-19 lockdown, there were fewer cases of mild skin issues and more cases of stress-related skin conditions.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

The letter suggests testosterone replacement therapy might worsen COVID-19 outcomes.

People with blood group O may have a higher risk of developing post-COVID-19 syndrome.